ASX RELEASE 14 November 2016 Mackie Research Capital appointed...

ASX RELEASE

14 November 2016

Mackie Research Capital appointed lead manager for TSX-V capital raising MMJ PhytoTech Limited (ASX: MMJ) (“MMJ” or “the Company”) is pleased to advise that Canadian-based Mackie Research Capital Corporation (“Mackie Research”) has been appointed as lead manager for the equity financing (“Financing”) component of the Company’s proposed TSX-V listing (“the Transaction”). MMJ has entered into a binding Term Sheet with Canadian-based Harvest One Capital Corp. (“Harvest One”) (TSXV NEX: WON. H) for the sale to Harvest One of 100% of the issued shares of United Greeneries Holdings Ltd (“UG”) and Satipharm AG (“Satipharm”) respectively. Under the terms of the agreement, Harvest One will undertake an equity financing to raise up to C$15,000,000 through the issue of shares at C$0.75 each. Post spin out, MMJ shareholders will have an indirect ownership in a fully-financed cannabis company (“New Entity”) with two core brands operating in one of the fastest growing cannabis markets globally.

This is not new news! What is everyone whining about. Was always part of the deal. I think half the people on here should sell there shares and bugger off